Prenatal dexamethasone programs hypertension and renal injury in the rat

Luis A. Ortiz, Albert Quan, Francisco Zarzar, Arthur Weinberg, Michel Baum

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

Dexamethasone is frequently administered to the developing fetus to accelerate pulmonary development. The purpose of the present study was to determine if prenatal dexamethasone programmed a progressive increase in blood pressure and renal injury in rats. Pregnant rats were given either vehicle or 2 daily intraperitoneal injections of dexamethasone (0.2 mg/kg body weight) on gestational days 11 and 12, 13 and 14, 15 and 16, 17 and 18, or 19 and 20. Offspring of rats administered dexamethasone on days 15 and 16 gestation had a 20% reduction in glomerular number compared with control at 6 to 9 months of age (22 527±509 versus 28 050±561, P<0.05), which was comparable to the percent reduction in glomeruli measured at 3 weeks of age. Six- to 9-month old rats receiving prenatal dexamethasone on days 17 and 18 of gestation had a 17% reduction in glomeruli (23 380±587) compared with control rats (P<0.05). Male rats that received prenatal dexamethasone on days 15 and 16, 17 and 18, and 13 and 14 of gestation had elevated blood pressures at 6 months of age; the latter group did not have a reduction in glomerular number. Adult rats given dexamethasone on days 15 and 16 of gestation had more glomeruli with glomerulosclerosis than control rats. This study shows that prenatal dexamethasone in rats results in a reduction in glomerular number, glomerulosclerosis, and hypertension when administered at specific points during gestation. Hypertension was observed in animals that had a reduction in glomeruli as well as in a group that did not have a reduction in glomerular number, suggesting that a reduction in glomerular number is not the sole cause for the development of hypertension.

Original languageEnglish (US)
Pages (from-to)328-334
Number of pages7
JournalHypertension
Volume41
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Renal Hypertension
Dexamethasone
Wounds and Injuries
Pregnancy
Hypertension
Blood Pressure
Intraperitoneal Injections
Fetus
Body Weight
Kidney
Lung

Keywords

  • Glomerular filtration rate
  • Glucocorticoids
  • Hypertension, gestational
  • Kidney

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Prenatal dexamethasone programs hypertension and renal injury in the rat. / Ortiz, Luis A.; Quan, Albert; Zarzar, Francisco; Weinberg, Arthur; Baum, Michel.

In: Hypertension, Vol. 41, No. 2, 01.02.2003, p. 328-334.

Research output: Contribution to journalArticle

Ortiz, Luis A. ; Quan, Albert ; Zarzar, Francisco ; Weinberg, Arthur ; Baum, Michel. / Prenatal dexamethasone programs hypertension and renal injury in the rat. In: Hypertension. 2003 ; Vol. 41, No. 2. pp. 328-334.
@article{bcbb8813cc2b41469036863d6f44770b,
title = "Prenatal dexamethasone programs hypertension and renal injury in the rat",
abstract = "Dexamethasone is frequently administered to the developing fetus to accelerate pulmonary development. The purpose of the present study was to determine if prenatal dexamethasone programmed a progressive increase in blood pressure and renal injury in rats. Pregnant rats were given either vehicle or 2 daily intraperitoneal injections of dexamethasone (0.2 mg/kg body weight) on gestational days 11 and 12, 13 and 14, 15 and 16, 17 and 18, or 19 and 20. Offspring of rats administered dexamethasone on days 15 and 16 gestation had a 20{\%} reduction in glomerular number compared with control at 6 to 9 months of age (22 527±509 versus 28 050±561, P<0.05), which was comparable to the percent reduction in glomeruli measured at 3 weeks of age. Six- to 9-month old rats receiving prenatal dexamethasone on days 17 and 18 of gestation had a 17{\%} reduction in glomeruli (23 380±587) compared with control rats (P<0.05). Male rats that received prenatal dexamethasone on days 15 and 16, 17 and 18, and 13 and 14 of gestation had elevated blood pressures at 6 months of age; the latter group did not have a reduction in glomerular number. Adult rats given dexamethasone on days 15 and 16 of gestation had more glomeruli with glomerulosclerosis than control rats. This study shows that prenatal dexamethasone in rats results in a reduction in glomerular number, glomerulosclerosis, and hypertension when administered at specific points during gestation. Hypertension was observed in animals that had a reduction in glomeruli as well as in a group that did not have a reduction in glomerular number, suggesting that a reduction in glomerular number is not the sole cause for the development of hypertension.",
keywords = "Glomerular filtration rate, Glucocorticoids, Hypertension, gestational, Kidney",
author = "Ortiz, {Luis A.} and Albert Quan and Francisco Zarzar and Arthur Weinberg and Michel Baum",
year = "2003",
month = "2",
day = "1",
doi = "10.1161/01.HYP.0000049763.51269.51",
language = "English (US)",
volume = "41",
pages = "328--334",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Prenatal dexamethasone programs hypertension and renal injury in the rat

AU - Ortiz, Luis A.

AU - Quan, Albert

AU - Zarzar, Francisco

AU - Weinberg, Arthur

AU - Baum, Michel

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Dexamethasone is frequently administered to the developing fetus to accelerate pulmonary development. The purpose of the present study was to determine if prenatal dexamethasone programmed a progressive increase in blood pressure and renal injury in rats. Pregnant rats were given either vehicle or 2 daily intraperitoneal injections of dexamethasone (0.2 mg/kg body weight) on gestational days 11 and 12, 13 and 14, 15 and 16, 17 and 18, or 19 and 20. Offspring of rats administered dexamethasone on days 15 and 16 gestation had a 20% reduction in glomerular number compared with control at 6 to 9 months of age (22 527±509 versus 28 050±561, P<0.05), which was comparable to the percent reduction in glomeruli measured at 3 weeks of age. Six- to 9-month old rats receiving prenatal dexamethasone on days 17 and 18 of gestation had a 17% reduction in glomeruli (23 380±587) compared with control rats (P<0.05). Male rats that received prenatal dexamethasone on days 15 and 16, 17 and 18, and 13 and 14 of gestation had elevated blood pressures at 6 months of age; the latter group did not have a reduction in glomerular number. Adult rats given dexamethasone on days 15 and 16 of gestation had more glomeruli with glomerulosclerosis than control rats. This study shows that prenatal dexamethasone in rats results in a reduction in glomerular number, glomerulosclerosis, and hypertension when administered at specific points during gestation. Hypertension was observed in animals that had a reduction in glomeruli as well as in a group that did not have a reduction in glomerular number, suggesting that a reduction in glomerular number is not the sole cause for the development of hypertension.

AB - Dexamethasone is frequently administered to the developing fetus to accelerate pulmonary development. The purpose of the present study was to determine if prenatal dexamethasone programmed a progressive increase in blood pressure and renal injury in rats. Pregnant rats were given either vehicle or 2 daily intraperitoneal injections of dexamethasone (0.2 mg/kg body weight) on gestational days 11 and 12, 13 and 14, 15 and 16, 17 and 18, or 19 and 20. Offspring of rats administered dexamethasone on days 15 and 16 gestation had a 20% reduction in glomerular number compared with control at 6 to 9 months of age (22 527±509 versus 28 050±561, P<0.05), which was comparable to the percent reduction in glomeruli measured at 3 weeks of age. Six- to 9-month old rats receiving prenatal dexamethasone on days 17 and 18 of gestation had a 17% reduction in glomeruli (23 380±587) compared with control rats (P<0.05). Male rats that received prenatal dexamethasone on days 15 and 16, 17 and 18, and 13 and 14 of gestation had elevated blood pressures at 6 months of age; the latter group did not have a reduction in glomerular number. Adult rats given dexamethasone on days 15 and 16 of gestation had more glomeruli with glomerulosclerosis than control rats. This study shows that prenatal dexamethasone in rats results in a reduction in glomerular number, glomerulosclerosis, and hypertension when administered at specific points during gestation. Hypertension was observed in animals that had a reduction in glomeruli as well as in a group that did not have a reduction in glomerular number, suggesting that a reduction in glomerular number is not the sole cause for the development of hypertension.

KW - Glomerular filtration rate

KW - Glucocorticoids

KW - Hypertension, gestational

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=0037313493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037313493&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000049763.51269.51

DO - 10.1161/01.HYP.0000049763.51269.51

M3 - Article

VL - 41

SP - 328

EP - 334

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -